High-dose Factor XIII administration induces effective hemostasis for trauma-associated coagulopathy (TAC) both in vitro and in rat hemorrhagic shock in vivo models

The Journal of Trauma and Acute Care Surgery
Futoshi NagashimaKeita Kai

Abstract

Trauma-associated coagulopathy (TAC) is an early and primary complication in severe trauma patients. Factor XIII (FXIII) is reported to stabilize a clot in the late phase of the coagulation cascade. The goal of this study was to investigate whether the administration of FXIII improves the condition of TAC both in vitro and in vivo. We evaluated the effects of different doses, including a very high dose of FXIII (3.6-32.4 IU/mL) on tissue-plasminogen activator-induced hyperfibrinolysis and the combined condition of dilutional coagulopathy and tissue-plasminogen activator-induced hyperfibrinolysis in vitro. The coagulation status was analyzed by rotational thromboelastometry (ROTEM) and Sonoclot. Then, we evaluated the effect of high-dose FXIII (300 IU/kg) for severe coagulopathy in vivo using a rat liver trauma model in which coagulopathy similar to TAC was observed. Survival time and the amount of intra-abdominal bleeding of rats were measured, and a coagulation test was also performed. Histologic evaluations of rats' lung and kidney after FXIII administration were completed. High-dose FXIII significantly improved clot strength as well as increased resistance to hyperfibrinolysis in vitro which was confirmed by ROTEM. Platelet ...Continue Reading

References

Dec 1, 1995·British Journal of Anaesthesia·D A HettD C Smith
Oct 14, 2005·Critical Care : the Official Journal of the Critical Care Forum·David S Kauvar, Charles E Wade
Aug 5, 2008·Cardiovascular & Hematological Agents in Medicinal Chemistry·L MuszbekE Katona
Sep 4, 2008·Thrombosis and Haemostasis·Jolanta M Siller-MatulaBernd Jilma
Jan 13, 2009·Injury·L M G GeeraedtsJ P M Frölke
Feb 26, 2009·Acta Anaesthesiologica Scandinavica·A A SchramkoT T Niemi
Dec 10, 2009·Blood·Kohji KasaharaAkitada Ichinose
May 1, 2010·Thrombosis and Haemostasis·Oliver M TheusingerDonat R Spahn
Jun 19, 2010·Blood·Voahanginirina RandriamboavonjyIngrid Fleming
Jan 26, 2011·Thrombosis and Haemostasis·A IchinoseUNKNOWN Japanese collaborative research group on "Acquired haemorrha-philia due to factor XIII deficiency"
Mar 29, 2011·Lancet·Ian RobertsJon Nicholl
Dec 17, 2011·The Journal of Trauma·Sandro B RizoliHomer C Tien
Apr 24, 2012·Journal of the American College of Surgeons·Max V WohlauerMark Walsh
Jun 30, 2012·The Journal of Trauma and Acute Care Surgery·Matthew E KutcherMitchell Jay Cohen
Aug 7, 2012·Journal of Cardiothoracic and Vascular Anesthesia·Kenichi A TanakaAlastair Nimmo
Jan 15, 2013·Annals of Intensive Care·Adrien BougléJacques Duranteau
Feb 2, 2013·Scandinavian Journal of Clinical and Laboratory Investigation·Dag WinstedtUlf Schött
Jun 13, 2013·Anesthesia and Analgesia·Herbert Schöchl, Christoph J Schlimp
Aug 15, 2013·The Journal of Trauma and Acute Care Surgery·Mitchell Jay CohenUNKNOWN PROMMTT Study Group
Aug 9, 2013·Journal of Cardiothoracic and Vascular Anesthesia·Klaus GörlingerKenichi A Tanaka
Sep 6, 2013·Scandinavian Journal of Clinical and Laboratory Investigation·Jennifer HannaUlf Schött
Nov 7, 2013·Shock·Marc MaegeleMitchell J Cohen
Jan 25, 2014·The Journal of Trauma and Acute Care Surgery·Lucy Z KornblithMitchell Jay Cohen
Dec 3, 2014·Anaesthesia·A Cap, B J Hunt
Apr 14, 2015·Journal of Cardiothoracic and Vascular Anesthesia·Dominique B BischofChristoph K Hofer
Jul 29, 2015·The Journal of Trauma and Acute Care Surgery·Geoffrey P DobsonAndrew P Cap
Apr 14, 2016·Critical Care : the Official Journal of the Critical Care Forum·Rolf RossaintDonat R Spahn

❮ Previous
Next ❯

Citations

Apr 26, 2020·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Ivan BudnikYulia Einav
Jul 16, 2019·Acute Medicine & Surgery·Tawnya VernonChet Morrison

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.